Unlocking the Power of Nano-medicine, Revolutionizing Opioid Therapy: A review

Objective: Opioids represent one of the oldest classes of drugs in medicine and remain
central to pain management. The aim of this literature review is to summarize the latest
research on opioid nano formulations and their ability to increase analgesic efficacy while
minimizing associated risks. Preclinical studies have already demonstrated that both
liposomal and dendrimer-based opioid formulations allow for extended release and,
consequently, more prolonged and stable analgesia.
Methodology: This narrative review was conducted to evaluate the role of NPs in opioid
based analgesia and in mitigating the harms associated with opioid use. Key methodologies
include formulation of nanocarriers, surface functionalization for targeted delivery, and
stimuli responsive release systems.
Results: Nano medicine improves opioid therapy by optimizing pharmacokinetics and drug
delivery system, which is helpful in maintaining analgesia and reducing the adverse effect.
Nanoformulations such as liposomes and dendrimer based opioid formulations allow
sustained, controlled drug release and have higher rate of bioavailability.
Conclusion: Nano medicine-based delivery systems represent promising tools for providing
effective analgesia for patients. Interdisciplinary collaboration among materials scientists,
pharmacologists, anesthesiologists, and regulatory authorities is essential for the
establishment of standardized evaluation pipelines for opioid nanoformulations. Only through
such coordinated efforts will nanomedicine evolve into a clinically reliable and widely
accessible tool for both effective and safe pain management. Keywords Nanoparticle,
liposomes, dendrimers, nanoemulsions, opioids.